What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome?

Mechanisms of Ageing and Development

Volumn 134, Issue 5-6, 2013, Pages 225-233

  Weiner, Alan M ^a   Gray, Lucas T ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

AP 1 family transcription factor (c Jun); CCCTC binding factor (CTCF); Fusion protein; Interferon (IFN); Piggybac derived element 3 (PGBD3)

Indexed keywords

CSB PGBD3 FUSION PROTEIN; DOUBLE STRANDED RNA; HYBRID PROTEIN; INTERFERON; PROTEIN C JUN; PROTEN TEAD1; RETINOIC ACID INDUCIBLE PROTEIN I; STAT PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; TRANSPOSASE; UNCLASSIFIED DRUG; VIRUS RNA;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL FEATURE; COCKAYNE SYNDROME; CSB GENE; CYTOKINE RESPONSE; ENDOSOME; EXON; GENE EXPRESSION; GENE INSERTION; GENETIC CONSERVATION; GENETIC REGULATION; HUMAN; INTRON; NONHUMAN; NULL CELL; PRIMATE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION ELONGATION; TRANSPOSON; UPREGULATION; VIRUS INFECTION;

ALTERNATIVE SPLICING; ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; COCKAYNE SYNDROME; DEAD-BOX RNA HELICASES; DNA HELICASES; DNA REPAIR ENZYMES; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; INTRONS; MUTANT CHIMERIC PROTEINS; RECEPTORS, RETINOIC ACID; RESPONSE ELEMENTS; RNA, DOUBLE-STRANDED; TRANSPOSASES;

PRIMATES;

EID: 84878013694     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2013.01.001     Document Type: Article

References (53)

1. Anindya R., Mari P.O., Kristensen U., Kool H., Giglia-Mari G., Mullenders L.H., Fousteri M., Vermeulen W., Egly J.M., Svejstrup J.Q. A ubiquitin-binding domain in Cockayne syndrome B required for transcription-coupled nucleotide excision repair. Molecular Cell 2010, 38:637-648.
2. Bailey A.D., Gray L.T., Pavelitz T., Newman J.C., Horibata K., Tanaka K., Weiner A.M. The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells. DNA Repair 2012, 11:488-501.
3. Beilharz M.W., Cummins J.M., Bennett A.L. Protection from lethal influenza virus challenge by oral type 1 interferon. Biochemical and Biophysical Research Communications 2007, 355:740-744.
4. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., Hoebe K. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annual Review of Immunology 2006, 24:353-389.
5. Bradsher J., Auriol J., Proietti de Santis L., Iben S., Vonesch J.L., Grummt I., Egly J.M. CSB is a component of RNA pol I transcription. Molecular Cell 2002, 10:819-829.
6. Brooks P.J., Cheng T.F., Cooper L. Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?. DNA Repair 2008, 7:834-848.
7. Cheon H., Stark G.R. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:9373-9378.
8. Cheon H., Yang J., Stark G.R. The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. Journal of Interferon and Cytokine Research 2011, 31:33-40.
9. Colditz I.G. Six costs of immunity to gastrointestinal nematode infections. Parasite Immunology 2008, 30:63-70.
10. Colella S., Nardo T., Botta E., Lehmann A.R., Stefanini M. Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum. Human Molecular Genetics 2000, 9:1171-1175.
11. Crow Y.J. Type I interferonopathies: a novel set of inborn errors of immunity. Annals of the New York Academy of Sciences 2011, 1238:91-98.
12. Ferris S.D., Sage R.D., Huang C.M., Nielsen J.T., Ritte U., Wilson A.C. Flow of mitochondrial DNA across a species boundary. Proceedings of the National Academy of Sciences of the United States of America 1983, 80:2290-2294.
13. Feschotte C., Pritham E.J. DNA transposons and the evolution of eukaryotic genomes. Annual Review of Genetics 2007, 41:331-368.
14. Feschotte C. Transposable elements and the evolution of regulatory networks. Nature Reviews Genetics 2008, 9:397-405.
15. Gray L.T., Weiner A.M. Ubiquitin recognition by the Cockayne syndrome group B protein: binding will set you free. Molecular Cell 2010, 38:621-622.
16. Gray L.T., Fong K.K., Pavelitz T., Weiner A.M. Tethering of the conserved piggyBac transposase fusion protein CSB-PGBD3 to chromosomal AP-1 proteins regulates expression of nearby genes in humans. PLoS Genetics 2012, 8:e1002972.
17. Hashimoto S., Suga T., Kudo E., Ihn H., Uchino M., Tateishi S. Adult-onset neurological degeneration in a patient with Cockayne syndrome and a null mutation in the CSB gene. Journal of Investigative Dermatology 2008, 128:1597-1599.
18. Hayward A.D., Wilson A.J., Pilkington J.G., Clutton-Brock T.H., Pemberton J.M., Kruuk L.E. Natural selection on a measure of parasite resistance varies across ages and environmental conditions in a wild mammal. Journal of Evolutionary Biology 2011, 24:1664-1676.
19. Horibata K., Iwamoto Y., Kuraoka I., Jaspers N.G., Kurimasa A., Oshimura M., Ichihashi M., Tanaka K. Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15410-15415.
20. Horibata K., Saijo M., Bay M.N., Lan L., Kuraoka I., Brooks P.J., Honma M., Nohmi T., Yasui A., Tanaka K. Mutant Cockayne syndrome group B protein inhibits repair of DNA topoisomerase I-DNA covalent complex. Genes Cells 2011, 16:101-114.
21. Karahalil B., Bohr V., Wilson D. Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk. Human and Experimental Toxicology 2012, 31:981-1005.
22. Kaukinen P., Sillanpaa M., Nousiainen L., Melen K., Julkunen I. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKepsilon and TBK1 functions. Journal of Medical Virology 2013, 85:71-82.
23. Keith J.H., Schaeper C.A., Fraser T.S., Fraser M.J. Mutational analysis of highly conserved aspartate residues essential to the catalytic core of the piggyBac transposase. BMC Molecular Biology 2008, 9:73.
24. Kingsolver J.G., Hoekstra H.E., Hoekstra J.M., Berrigan D., Vignieri S.N., Hill C.E., Hoang A., Gibert P., Beerli P. The strength of phenotypic selection in natural populations. American Naturalist 2001, 157:245-261.
25. Kumthip K., Chusri P., Jilg N., Zhao L., Fusco D.N., Zhao H., Goto K., Cheng D., Schaefer E.A., Zhang L., Pantip C., Thongsawat S., O'Brien A., Peng L.F., Maneekarn N., Chung R.T., Lin W. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. Journal of Virology 2012, 86:8581-8591.
26. Lake R.J., Geyko A., Hemashettar G., Zhao Y., Fan H.Y. UV-induced association of the CSB remodeling protein with chromatin requires ATP-dependent relief of N-terminal autorepression. Molecular Cell 2010, 37:235-246.
27. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B., Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L., Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y., Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C., Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W., Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P., Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M., Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A., Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A., Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M., Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R., Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A., Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J., Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N., Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L., Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G., Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R., Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G., Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W., Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J., Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M., McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J., Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E., Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J., Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F., Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A., Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K., Shizuya H., Choi S., Chen Y.J. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
28. Laugel V., Dalloz C., Stary A., Cormier-Daire V., Desguerre I., Renouil M., Fourmaintraux A., Velez-Cruz R., Egly J.M., Sarasin A., Dollfus H. Deletion of 5′ sequences of the CSB gene provides insight into the pathophysiology of Cockayne syndrome. European Journal of Human Genetics 2008, 16:320-327.
29. Laugel V., Dalloz C., Tobias E.S., Tolmie J.L., Martin-Coignard D., Drouin-Garraud V., Valayannopoulos V., Sarasin A., Dollfus H. Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation. Journal of Medical Genetics 2008, 45:564-571.
30. Laugel V., Dalloz C., Durand M., Sauvanaud F., Kristensen U., Vincent M.C., Pasquier L., Odent S., Cormier-Daire V., Gener B., Tobias E.S., Tolmie J.L., Martin-Coignard D., Drouin-Garraud V., Heron D., Journel H., Raffo E., Vigneron J., Lyonnet S., Murday V., Gubser-Mercati D., Funalot B., Brueton L., Sanchez Del Pozo J., Munoz E., Gennery A.R., Salih M., Noruzinia M., Prescott K., Ramos L., Stark Z., Fieggen K., Chabrol B., Sarda P., Edery P., Bloch-Zupan A., Fawcett H., Pham D., Egly J.M., Lehmann A.R., Sarasin A., Dollfus H. Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Human Mutation 2010, 31:113-126.
31. Lebedev A., Scharffetter-Kochanek K., Iben S. Truncated Cockayne syndrome B protein represses elongation by RNA polymerase I. Journal of Molecular Biology 2008, 382:266-274.
32. Li X., Ewis H., Hice R.H., Malani N., Parker N., Zhou L., Feschotte C., Bushman F.D., Atkinson P.W., Craig N.L. A resurrected mammalian hAT transposable element and a closely related insect element are highly active in human cell culture. Proceedings of the National Academy of Sciences of the United States of America 2012, 109. (Epub ahead of print).
33. Livingston J.H., Stivaros S., MS V.D.K., Crow Y.J. Recognizable phenotypes associated with intracranial calcification. Developmental Medicine and Child Neurology 2012, 55:46-57.
34. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nature Biotechnology 2010, 28:495-501.
35. Mitra R., Fain-Thornton J., Craig N.L. piggyBac can bypass DNA synthesis during cut and paste transposition. EMBO Journal 2008, 27:1097-1109.
36. Montaño S.P., Pigli Y.Z., Rice P.A. The Mu transpososome structure sheds light on DDE recombinase evolution. Nature 2012, 491:413-417.
37. Nance M.A., Berry S.A. Cockayne syndrome: review of 140 cases. American Journal of Medical Genetics 1992, 42:68-84.
38. Neumann F.R., Dion V., Gehlen L.R., Tsai-Pflugfelder M., Schmid R., Taddei A., Gasser S.M. Targeted INO80 enhances subnuclear chromatin movement and ectopic homologous recombination. Genes and Development 2012, 26:369-383.
39. Newman J.C., Weiner A.M. L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biology 2005, 6:R81.
40. Newman J.C., Bailey A.D., Weiner A.M. Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:9613-9618.
41. Newman J.C., Bailey A.D., Fan H.Y., Pavelitz T., Weiner A.M. An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome. PLoS Genetics 2008, 4:e1000031.
42. Niedernhofer L.J., Garinis G.A., Raams A., Lalai A.S., Robinson A.R., Appeldoorn E., Odijk H., Oostendorp R., Ahmad A., van Leeuwen W., Theil A.F., Vermeulen W., van der Horst G.T., Meinecke P., Kleijer W.J., Vijg J., Jaspers N.G., Hoeijmakers J.H. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006, 444:1038-1043.
43. Niwa M., Rose S.D., Berget S.M. In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes and Development 1990, 4:1552-1559.
44. Rice G.I., Kasher P.R., Forte G.M., Mannion N.M., Greenwood S.M., Szynkiewicz M., Dickerson J.E., Bhaskar S.S., Zampini M., Briggs T.A., Jenkinson E.M., Bacino C.A., Battini R., Bertini E., Brogan P.A., Brueton L.A., Carpanelli M., De Laet C., de Lonlay P., Del Toro M., Desguerre I., Fazzi E., Garcia-Cazorla A., Heiberg A., Kawaguchi M., Kumar R., Lin J.P., Lourenco C.M., Male A.M., Marques W., Mignot C., Olivieri I., Orcesi S., Prabhakar P., Rasmussen M., Robinson R.A., Rozenberg F., Schmidt J.L., Steindl K., Tan T.Y., van der Merwe W.G., Vanderver A., Vassallo G., Wakeling E.L., Wassmer E., Whittaker E., Livingston J.H., Lebon P., Suzuki T., McLaughlin P.J., Keegan L.P., O'Connell M.A., Lovell S.C., Crow Y.J. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nature Genetics 2012, 44:1243-1248.
45. Stetson D.B. Endogenous retroelements and autoimmune disease. Current Opinion in Immunology 2012, 24:692-697.
46. Sunesen M., Selzer R.R., Brosh R.M., Balajee A.S., Stevnsner T., Bohr V.A. Molecular characterization of an acidic region deletion mutant of Cockayne syndrome group B protein. Nucleic Acids Research 2000, 28:3151-3159.
47. Tan J., Pan R., Qiao L., Zou X., Pan Z. Modeling and dynamical analysis of virus-triggered innate immune signaling pathways. PLoS ONE 2012, 7:e48114.
48. van der Pluijm I., Garinis G.A., Brandt R.M., Gorgels T.G., Wijnhoven S.W., Diderich K.E., de Wit J., Mitchell J.R., van Oostrom C., Beems R., Niedernhofer L.J., Velasco S., Friedberg E.C., Tanaka K., van Steeg H., Hoeijmakers J.H., van der Horst G.T. Impaired genome maintenance suppresses the growth hormone - insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biology 2007, 5:e2.
49. Wan S., Pestka S., Jubin R.G., Lyu Y.L., Tsai Y.C., Liu L.F. Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS ONE 2012, 7:e32542.
50. Wu S.C., Meir Y.J., Coates C.J., Handler A.M., Pelczar P., Moisyadi S., Kaminski J.M. Piggybac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:15008-15013.
51. Wyles D.L. Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection. Topics in Antiviral Medicine 2012, 20:139-145.
52. Yu A., Fan H.Y., Liao D., Bailey A.D., Weiner A.M. Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2, and 5S genes. Molecular Cell 2000, 5:801-810.
53. Yusa K., Zhou L., Li M.A., Bradley A., Craig N.L. A hyperactive piggyBac transposase for mammalian applications. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:1531-1536.